Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2025-07-21 00:00:00 ET · period of report 2025-07-17 · accession 0000950170-25-097279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-21 | 2025-07-17 | APVO | Abdun-Nabi Daniel | Dir | M - OptEx | — | +1 | 1 | New | — |
| D | 2025-07-21 | 2025-07-17 | APVO | Abdun-Nabi Daniel | Dir | M - OptEx | $0.00 | -1 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-17 | M | A | 1 | — | 1 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2025-07-17 | M | D | 1 | $0.00 | 0 | D | — · — to — | 1 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant. |